BAZ1A and prostate cancer: We also mined three publicly available datasets to identify and subsequently test a mechanism for BAZ1A, a member of the ATP-dependent ACF-1/5 ISWI chromatin remodeling complex, to suppress VDR signaling in AA prostate cancer; an overview of the workflow is shown in Supplementary Fig. S1.